Man Group’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.8M Buy
124,293
+60,015
+93% +$697K ﹤0.01% 1614
2025
Q4
$618K Buy
64,278
+49,500
+335% +$474K ﹤0.01% 1834
2025
Q3
$139K Buy
14,778
+1,510
+11% +$14.4K ﹤0.01% 2137
2025
Q2
$140K Buy
+13,268
New +$167K ﹤0.01% 2106
2024
Q1
Sell
-29,700
Closed -$673K 2109
2023
Q4
$673K Buy
+29,700
New +$615K ﹤0.01% 1573
2023
Q3
Sell
-25,700
Closed -$533K 1512
2023
Q2
$668K Buy
+25,700
New +$688K ﹤0.01% 1501
2023
Q1
Sell
-12,000
Closed -$357K 1652
2022
Q4
$355K Buy
+12,000
New +$341K ﹤0.01% 1600
2018
Q4
Sell
-31,621
Closed -$1.33M 1904
2018
Q3
$1.33M Sell
31,621
-6,195
-16% -$245K ﹤0.01% 1558
2018
Q2
$1.21M Buy
37,816
+26,803
+243% +$1.1M 0.01% 1548
2018
Q1
$548K Buy
+11,013
New +$622K ﹤0.01% 1691

Other funds holding ANIK